Skip to main content
Emery P, van Keep M, Beard SM, Graham CN, Miles L, Jugl SM, Gunda P, Halliday A, Marzo-Ortega H. Cost-effectiveness of secukinumab for the treatment of active ankylosing spondylitis in the UK. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 6, 2017. Glasgow, Scotland.
Marzo-Ortega H, Halliday A, Jugl S, Mokashi S, Gunda P, Graham CN, Miles L, Beard S, van Keep M. The cost-effectiveness of secukinumab versus tumour necrosis factor alpha inhibitor biosimilars for ankylosing spondylitis in the UK. Poster presented at the British Society for Rheumatology 2017; April 25, 2017. Birmingham, United Kingdom.